Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.
Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, Griffin ML, Gourevitch MN, Haller DL, Hasson AL, Huang Z, Jacobs P, Kosinski AS, Lindblad R, McCance-Katz EF, Provost SE, Selzer J, Somoza EC, Sonne SC, Ling W. Weiss RD, et al. Among authors: selzer j. Arch Gen Psychiatry. 2011 Dec;68(12):1238-46. doi: 10.1001/archgenpsychiatry.2011.121. Epub 2011 Nov 7. Arch Gen Psychiatry. 2011. PMID: 22065255 Free PMC article. Clinical Trial.
Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.
Dreifuss JA, Griffin ML, Frost K, Fitzmaurice GM, Potter JS, Fiellin DA, Selzer J, Hatch-Maillette M, Sonne SC, Weiss RD. Dreifuss JA, et al. Among authors: selzer j. Drug Alcohol Depend. 2013 Jul 1;131(1-2):112-8. doi: 10.1016/j.drugalcdep.2012.12.010. Epub 2013 Jan 18. Drug Alcohol Depend. 2013. PMID: 23333292 Free PMC article. Clinical Trial.
Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials.
Donovan DM, Bigelow GE, Brigham GS, Carroll KM, Cohen AJ, Gardin JG, Hamilton JA, Huestis MA, Hughes JR, Lindblad R, Marlatt GA, Preston KL, Selzer JA, Somoza EC, Wakim PG, Wells EA. Donovan DM, et al. Among authors: selzer ja. Addiction. 2012 Apr;107(4):694-708. doi: 10.1111/j.1360-0443.2011.03473.x. Epub 2011 Jul 22. Addiction. 2012. PMID: 21781202 Free PMC article.
Buprenorphine tapering schedule and illicit opioid use.
Ling W, Hillhouse M, Domier C, Doraimani G, Hunter J, Thomas C, Jenkins J, Hasson A, Annon J, Saxon A, Selzer J, Boverman J, Bilangi R. Ling W, et al. Among authors: selzer j. Addiction. 2009 Feb;104(2):256-65. doi: 10.1111/j.1360-0443.2008.02455.x. Addiction. 2009. PMID: 19149822 Free PMC article. Clinical Trial.
Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs?
Nunes EV, Ball S, Booth R, Brigham G, Calsyn DA, Carroll K, Feaster DJ, Hien D, Hubbard RL, Ling W, Petry NM, Rotrosen J, Selzer J, Stitzer M, Tross S, Wakim P, Winhusen T, Woody G. Nunes EV, et al. Among authors: selzer j. J Subst Abuse Treat. 2010 Jun;38 Suppl 1(Suppl 1):S97-112. doi: 10.1016/j.jsat.2010.01.012. J Subst Abuse Treat. 2010. PMID: 20307801 Free PMC article.
Schizophrenia and substance abuse.
Selzer JA, Lieberman JA. Selzer JA, et al. Psychiatr Clin North Am. 1993 Jun;16(2):401-12. Psychiatr Clin North Am. 1993. PMID: 8332568 Review.
54 results